Supernus Pharmaceuticals | SUPN - DŁUG





DŁUG Zmiana Data
Abbott USD 13.86B 919M 2025-12
ANI Pharmaceuticals USD 617.04M 3.28M 2025-12
Aurora Cannabis CAD 100.34M 1.29M 2025-09
Bristol-Myers Squibb USD 47.14B 3.9B 2025-12
Canopy Growth CAD 259.33M 68.47M 2025-09
Cara Therapeutics USD 0 0 2025-03
Corcept Therapeutics USD 6.11M 251K 2025-12
Eisai JPY 236.67B 49.14B 2025-09
Eli Lilly USD 42.5B 3.6M 2025-12
Novo Nordisk DKK 118.72B 61.75B 2025-03
Pacira USD 367.66M 4.53M 2026-03
Perrigo USD 3.64B 4.5M 2025-12
Pfizer USD 63.73B 231M 2026-03
Supernus Pharmaceuticals USD 40.98M 1.23M 2025-12
United Therapeutics USD 200M 100M 2025-03
Xeris Pharmaceuticals USD 257.65M 431K 2025-09